You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 7, April 9, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Prognosis/ Outcomes
 •Drug Therapy, Other
 •Immunology, Other
 •Alert me on articles by topic

Success of Clinical Care for Human Immunodeficiency Virus Infection According to Demographic Group Among Sexually Infected Patients in a Routine Clinic Population, 1999 to 2004

Fiona C. Lampe, PhD; Colette J. Smith, MSc; Sara Madge, MD; Sabine Kinloch–de Loes, MD; Mervyn Tyrer, MD; Caroline A. Sabin, PhD; Clinton Chaloner, MSc; Mike Youle, MB, ChB; Margaret A. Johnson, MD; Andrew N. Phillips, PhD

Arch Intern Med. 2007;167(7):692-700.

Background  The success of clinical care for human immunodeficiency virus infection may vary across demographic groups, because of patient- and health care–related factors.

Methods  A total of 2386 patients sexually infected with the human immunodeficiency virus were seen in a London clinic from July 1, 1999, to December 31, 2004. We examined demographic variation and trends over time in the prevalence of the following: (1) a CD4 cell count of 200/µL or less; (2) a viral load of greater than 50 copies/mL among patients receiving antiretroviral therapy (ART); and (3) a viral load of greater than 50 copies/mL among patients receiving ART for 24 weeks or longer.

Results  Subjects were homosexual men (63.1%), white heterosexual men (4.3%) and women (5.1%), and black African or other ethnicity heterosexual men (10.2%) and women (17.3%). The CD4 cell count at the first clinic visit was highest among homosexual men and lowest among black African heterosexual men. From 1999 to 2004, ART use increased from 61.9% to 75.5%. The prevalence of a CD4 cell count of 200/µL or less decreased from 19.6% to 9.0%. The prevalence of a viral load of greater than 50 copies/mL decreased from 36.9% to 14.5% among patients receiving ART, and from 31.2% to 10.1% among patients receiving ART for 24 weeks or longer. Demographic variation in the prevalence of each outcome was apparent among men throughout the period: homosexual men had the most favorable profile, and black African heterosexual men had the least favorable profile. Differences were much greater for low CD4 cell count than for raised viral load while receiving ART. There was no consistent demographic variation among women. Favorable trends over time occurred within each demographic group, and were as strong among black African patients as among other subgroups.

Conclusions  The success of clinical care for human immunodeficiency virus infection increased substantially from 1999 to 2004 in this routine clinic population. All demographic subgroups benefited from improvements, despite ongoing differences in the prevalence of immunosuppression.


Author Affiliations: Department of Primary Care and Population Sciences, Royal Free and University College Medical School (Drs Lampe, Sabin, and Phillips, Ms Smith, and Mr Chaloner), and Department of HIV Medicine, Royal Free Hospital (Drs Madge, Kinloch-de Loes, Tyrer, Youle, and Johnson), London, England.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment Responses: Getting Better All the Time
AIDS Clin Care 2007;2007:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.